Diagnostic Approach and Management of Reduced FEV1/FVC with Normal FVC

Understanding the Spirometric Pattern

A reduced FEV1/FVC ratio with normal FVC defines obstructive airway disease, indicating airflow limitation when FEV1/FVC is <0.7, according to the European Respiratory Society 1, 2, 3
Normal lung volumes are maintained, distinguishing this from restrictive disease where both FEV1 and FVC are reduced, as noted by the European Respiratory Society 4, 5
The obstruction is primarily due to increased airway resistance rather than loss of lung volume, as stated by the European Respiratory Society 4

The GOLD 2025 guidelines mandate post-bronchodilator spirometry to confirm COPD diagnosis, which involves administering salbutamol 400 mcg and reassessing spirometry 15 minutes after administration, as recommended by the European Respiratory Society 3, 6
A positive bronchodilator response is defined as improvement in FEV1 and/or FVC of ≥12% AND ≥200 mL from baseline, according to the European Respiratory Society 6, 5

Bronchodilator responsiveness does not reliably differentiate COPD from asthma, as many COPD patients demonstrate significant flow and/or volume responses, as noted by the European Respiratory Society 2, 7
Clinical history, reversibility pattern, and longitudinal follow-up are key factors in distinguishing between COPD and asthma, as stated by the European Respiratory Society 3, 2

Initiate treatment with inhaled bronchodilators regardless of the magnitude of acute bronchodilator response in the laboratory, as recommended by the European Respiratory Society 6
Lack of acute FEV1 response does not preclude clinical benefit, and many patients show volume responses without significant FEV1 improvement, as noted by the European Respiratory Society 6, 1, 7

Assess clinical response using multiple parameters, not just FEV1, including inspiratory capacity, residual volume, symptom improvement, and exercise tolerance, as recommended by the European Respiratory Society 6